Patents Assigned to The Steadman Clinic and Steadman Philippon Research Institute
  • Publication number: 20230287072
    Abstract: The present disclosure provides a method of delivery, treatment, and prevention of neuropathy and/or pain associated with NGF treatment for an underline disease or condition with a NGF mutant, such as NGFR100W, that does not elicit pain. The present disclosure further provides a composition of micro- and/or nano-rods attached with the NGF mutant, such as NGFR100W, which are injectable or administered to a target for desired therapies.
    Type: Application
    Filed: August 2, 2021
    Publication date: September 14, 2023
    Applicants: The Regents of the University of California, The Steadman Clinic & Steadman Philippon Research Institute
    Inventors: Chengbiao WU, Kijung SUNG, Chelsea Shileds BAHNEY, Kevin RIVERA, Tejal DESAI
  • Publication number: 20230226257
    Abstract: Methods of making decellularized tendon matrix (DTM) and DTM hydrogels are provided. These compositions and hydrogels are useful for repairing tendon injuries and in some cases may be used by injection, arthroscopic procedures, or as adjuncts to traditional surgical repair.
    Type: Application
    Filed: June 20, 2021
    Publication date: July 20, 2023
    Applicant: THE STEADMAN CLINIC AND STEADMAN PHILIPPON RESEARCH INSTITUTE
    Inventors: Chelsea S. BAHNEY, David BERNHOLT, Anna-Laura NELSON, Peter J. MILLETT
  • Publication number: 20220047775
    Abstract: Methods of making decellularized tendon matrix (DTM) and DTM hydrogels are provided. These compositions and hydrogels are useful for repairing tendon injuries and in some cases may be used by injection, arthroscopic procedures, or as adjuncts to traditional surgical repair.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 17, 2022
    Applicant: The Steadman Clinic and Steadman Philippon Research Institute
    Inventors: Chelsea S. BAHNEY, Peter J. MILLETT, David BERNHOLT, Anna-Laura NELSON